Henshaw Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,512	Closed	-$209K	–	265
2022 Q4	$209K	Buy	+4,512	New	+$177K	0.01%	229
2022 Q3	–	Sell	-4,512	Closed	-$269K	–	313
2022 Q2	$269K	Buy	4,512 +628	+16%	+$38.6K	0.02%	242
2022 Q1	$282K	Hold	3,884	–	–	0.02%	260
2021 Q4	$327K	Hold	3,884	–	–	0.02%	241
2021 Q3	$350K	Hold	3,884	–	–	0.02%	220
2021 Q2	$370K	Sell	3,884 -370	-9%	-$38.5K	0.02%	228
2021 Q1	$484K	Sell	4,254 -366	-8%	-$49.8K	0.03%	171
2020 Q4	$640K	Sell	4,620 -1,101	-19%	-$131K	0.05%	134
2020 Q3	$470K	Sell	5,721 -794	-12%	-$65.8K	0.04%	162
2020 Q2	$510K	Hold	6,515	–	–	0.04%	143
2020 Q1	$289K	Buy	+6,515	New	+$338K	0.03%	196